Gurus BioPharm is a R&D company developing innovative drugs. Our proprietary technology is based on prostaglandins and nitric oxide, it allows generating multi-functional first-in-class therapies for unmet medical needs.
We focus on endogenous molecules. Our platform allows to modify endogenous molecules such as prostaglandins. The platform generates multi-target endogenous drug candidates with advanced therapeutic efficacy. Being endogenous, our molecules have nearly zero toxicity.Read more
Synchronously affects several targets, causing significant disruption of the smooth muscles of the bronchi. First-in-class potential.
Simultaneous exposure to several targets allows to restore severe damage to peripheral arteries. Best-in-class potential.